In this article, we examine professional discourse around the development of polygenic risk-stratified screening (PRSS) for cancer. Analyzing a range of contemporary professional literatures from Europe, North America and Australia, we explore how the drive to screen for molecular markers of cancer risk makes professionals, screening recipients and publics responsible, in different ways, for acquiring, curating and analyzing molecular data. Investigating how these responsibilities are invoked in discussions of new data practices, technologies, organizational arrangements, engagement, education and protocols for participation, we argue that agendas for PRSS for cancer are both expanding and stratifying responsibilities. Data collection is to...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Advances in genomics have crucial implications for public health, offering new ways of differentiati...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
Using the principles of public health genomics, we examined the opportunities and challenges of impl...
Technological innovations including risk-stratification algorithms and large databases of longitudin...
Population-based genomic screening is at the forefront of a new approach to disease prevention. Yet ...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
For some common disorders (cancer, cardiovascular disease (CVD)) monogenic subtypes exist where vari...
Abstract Increasing amounts of genetic data have led to the development of polygenic risk scores (PR...
Developments in public health genomics (PHG) hold the promise to be beneficial for individuals and t...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
[À l'origine dans / Was originally part of : CRDP - Droit, biotechnologie et rapport au milieu]Publi...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Advances in genomics have crucial implications for public health, offering new ways of differentiati...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
In this article, we examine professional discourse around the development of polygenic risk-stratifi...
Using the principles of public health genomics, we examined the opportunities and challenges of impl...
Technological innovations including risk-stratification algorithms and large databases of longitudin...
Population-based genomic screening is at the forefront of a new approach to disease prevention. Yet ...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
For some common disorders (cancer, cardiovascular disease (CVD)) monogenic subtypes exist where vari...
Abstract Increasing amounts of genetic data have led to the development of polygenic risk scores (PR...
Developments in public health genomics (PHG) hold the promise to be beneficial for individuals and t...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...
[À l'origine dans / Was originally part of : CRDP - Droit, biotechnologie et rapport au milieu]Publi...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Advances in genomics have crucial implications for public health, offering new ways of differentiati...
Advances in genomics have near-term impact on diagnosis and management of monogenic disorders. For c...